SUBSCRIBE: Print / Digital / eNewsletter
Takeaways from a roundtable at ASHP 2019.
A preemptive pain management program involving OTC medications can help reduce the need for opioid prescriptions following certain surgeries.
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
FDA approval decision expected in the second quarter of 2020.
The opioid crisis continues to be one of the worst public health crises that the United States has ever seen.
Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.
Here are the top drugs expected to be approved this year.
NACDS says DIR fees, other policies need to change.
Individuals with a history of heart disease may be at an increased risk of developing kidney failure.
Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.
AstraZeneca’s supplemental New Drug Application for dapagliflozin (Farxiga) has been granted Priority Review by the FDA.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
